Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Auclerc

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
British Journal of Cancer|April 16, 2002
Day-care, early common infections and childhood acute leukaemia: a multicentre French case-control studyF Perrillat, J Clavel, M F Auclerc, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Experimental and clinical activity of a new anthracycline derivative: detorubicin (14-diethoxyacetoxydaunorubicin)R Maral, D Heusse, F Lavelle, et al.
British Journal of Cancer|December 6, 2000
Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis Of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE)J Donadieu, M F Auclerc, A Baruchel, et al.
Blood|January 1, 1980
Acute monoblastic leukemia: a clinical and biologic study of 74 casesG Tobelem, C Jacquillat, C Chastang, et al.
La Nouvelle Presse Medicale|December 13, 1980
[Acute monoblastic leukaemia. Clinical data and therapeutic results in 74 patients (author's transl)]C Jacquillat, G Tobelem, M F Auclerc, et al.
Bulletin Du Cancer|January 1, 1980
Application of the study of prognostic factors to the treatment of childhood (less than 20 years old) acute lymphoblastic leukemiaC Jacquillat, M Weil, M F Auclerc, et al.
British Journal of Haematology|August 29, 1998
Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables. Fralle group. French Acute Lymphoblastic Leukaemia study groupJ Donadieu, M F Auclerc, A Baruchel, et al.
British Journal of Haematology|November 14, 1997
The majority of myeloid-antigen-positive (My+) childhood B-cell precursor acute lymphoblastic leukaemias express TEL-AML1 fusion transcriptsA Baruchel, J M Cayuela, P Ballerini, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|April 22, 2004
Incidence of childhood leukaemia and non-Hodgkin's lymphoma in France: National Registry of Childhood Leukaemia and Lymphoma, 1990-1999J Clavel, A Goubin, M F Auclerc, et al.
Leukemia|December 16, 2006
Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in childrenM N Dufourg, J Landman-Parker, M F Auclerc, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
British Journal of Cancer|April 16, 2002
Day-care, early common infections and childhood acute leukaemia: a multicentre French case-control studyF Perrillat, J Clavel, M F Auclerc, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Experimental and clinical activity of a new anthracycline derivative: detorubicin (14-diethoxyacetoxydaunorubicin)R Maral, D Heusse, F Lavelle, et al.
British Journal of Cancer|December 6, 2000
Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis Of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE)J Donadieu, M F Auclerc, A Baruchel, et al.
Blood|January 1, 1980
Acute monoblastic leukemia: a clinical and biologic study of 74 casesG Tobelem, C Jacquillat, C Chastang, et al.
La Nouvelle Presse Medicale|December 13, 1980
[Acute monoblastic leukaemia. Clinical data and therapeutic results in 74 patients (author's transl)]C Jacquillat, G Tobelem, M F Auclerc, et al.
Bulletin Du Cancer|January 1, 1980
Application of the study of prognostic factors to the treatment of childhood (less than 20 years old) acute lymphoblastic leukemiaC Jacquillat, M Weil, M F Auclerc, et al.
British Journal of Haematology|August 29, 1998
Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables. Fralle group. French Acute Lymphoblastic Leukaemia study groupJ Donadieu, M F Auclerc, A Baruchel, et al.
British Journal of Haematology|November 14, 1997
The majority of myeloid-antigen-positive (My+) childhood B-cell precursor acute lymphoblastic leukaemias express TEL-AML1 fusion transcriptsA Baruchel, J M Cayuela, P Ballerini, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|April 22, 2004
Incidence of childhood leukaemia and non-Hodgkin's lymphoma in France: National Registry of Childhood Leukaemia and Lymphoma, 1990-1999J Clavel, A Goubin, M F Auclerc, et al.
Leukemia|December 16, 2006
Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in childrenM N Dufourg, J Landman-Parker, M F Auclerc, et al.
Pageof 6